Abstract
Insulin-like growth factors (IGFs) appear to play arole in the development of tumors in generaland brain tumors in particular. Specific receptors forIGFs have been identified in normal human andrat brain, and evidence suggests that components ofthe IGF signal transduction system may play arole in the transformation process. Secretion of IGFsby a variety of human brain tumors hasbeen confirmed, and these growth factors appear tohave an autocrine stimulatory effect on these tumors.IGFs circulate in the blood stream bound toat least six distinct binding proteins which maymodulate the effects of these growth factors ontarget tissues. Sex steroids may also regulate thebehavior of certain brain tumors such as meningiomasat least in part through their effects onthe expression of IGFs and their binding proteins.Recently, antisense gene technology against certain IGFs ortheir receptors have resulted in potent antitumor effectsin the case of several gliomas, although themechanism for this remains unclear.
Similar content being viewed by others
References
Froesch RG, Busby WH, Schwander J, et al: Actions of insulin-like growth factors. Ann Rev Physiol 47: 443–467, 1985
McMorris FA, Smith TM, DeSalvo S et al: Insulin-like growth factor I/somato-medin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA 82: 7126–30, 1986
Rechler MM, Nissley SP: The nature and regulation of the receptors for insulin-like growth factors. Annu Rev Physiol 47: 425–442, 1985
Zapf J, Schoenle E, Froesch ER: Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constitutents of non-supressible insulin-like activity of human serum. Eur J Biochem 87: 285–296, 1978
Zapf J, Schmid C, Froesch ER: Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab 13: 3–30, 1984
Rotwein P, Burgess SK, Milbrandt JD et al: Differential expression of insulin-like growth factor genes in rat CNS. Proc Natl Acad Sci USA 85: 265–9, 1988
Sandberg AC, Engberg C, Lake M et al: Expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in gliomas. Neurosci Lett 93: 114–119, 1988
Haselbachler G K, Schwab ME, Pasi A, Humbel RE: Insulin like growth factor II (IGF II) in human brain: regional distribution of IGF II and higher molecular mass forms. Proc Natl Acad Sci USA 82: 2153–2157, 1985
Baskin DG, Wilcox BJ, Figelwicz DP et al: Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11: 107–111, 1988
Sara VR, Carlsson-Skiwut C: The role of the insulin-like growth factors in the regulation of brain development. Prog Brain Res 73: 87–99, 1988
Sara VR, Hall K, Misaki M et al: Ontogenesis of somatomedin and insulin receptors in the human fetus. J Clin Invest 71: 1084–1094, 1983
Lesniak M A, Hill JM, Kiess W, et al: Receptors for insulinlike growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 123: 2089–2099, 1989
Sara VR, Hall K, Von Holtz H, et al: Evidence for the presence of specific receptors of insulin-like growth factors I (IGF-I) and 2 (IGF-2 and insulin throughout the adult human brain. Neurosci Lett 34: 39–44, 1982
Lenoir D, Honegger P: Insulin-like growth factor I (IGF-1) stimulates DNA synthesis in fetal rat brain cell cultures. Brain Res 283: 2055–213, 1983
Mill JF, Chao MV, Ishh DN: Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation. Proc Natl Acad Sci USA 82: 7126–7130, 1985
Lim R, Miller JF, Hicklin JF, Holm A, Ginsberg BH: Mitogenic activity of glial maturation factor. Exp Cell Res 159: 334–343, 1985
Shemer J, Raizada MK, Masters BA, Ota A, LeRoith D: Insulin-like growth factor I receptors in neuronal and glial cells. J Biol Chem 262: 7693–7699, 1987
Kadle R, Suskang C, Adle R, Suskang C, Roberson EC, Fellows RE: Identification of an insulin-like factor in astrocyte conditioned medium. Brain Res 460: 60–67, 1988
Balottie R, Nielson FC, Pringle N, Kowalski A, Richardson WD Van Obberghen E, Gammeltoft S: Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. EMBO J 6: 3633–3639, 1987
Shambaugh G, Unterman TG, Glick RP, Kelly GC, Radosevich JA: Neonatal rat cerebellar cells: a model for study of production and regulation of IGF-II in the CNS. In Proc of the 2nd Internat. Symposium on IGFs, San Francisco, CA, p 157, 1991
Unterman TG, Simmons R, Glick RP, Ogata ES: Circulating levels of insulin, insulin-like growth factor (IGF)-I and-II and IGF binding proteins (IGFBPs) in the small for gestational age fetal rat. Endocrinology 132: 327–336, 1993
Blatt J, White, Dienes S et al: Production of an insulin-like growth factor by osteosarcoma. Biochem Biophys Res Commun 123: 373–336, 1984
Huff KK, Kaufman D, Gabbay KH et al: Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 46: 4613–4619, 1990
Jaques G, Rotsch M, Wegamnn C et al: Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cancer cell lines. Exp Cell Res 176: 336–343, 1988
Scott J, Cowell J, Robertson ME et al: Insulin-like growth factor-II production in Wilm’s tumour and embryonic tissues. Nature 317: 260–262 (letter), 1985
Tricoli JV, Rall LB, Karakousis C et al: Enhanced levels of insulin-like growth factor messenger mRNA in human colon carcinomas and liposarcomas. Cancer Res 46: 6169–6173, 1986
Prager D, Li H-S, Asa S, Melmed S: Dominant negative inhibition of tumorigenesis in vivoby human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91: 2181–85, 1994
Peterson JE, Jelinek T, Kaleko M, Siddle K, Weber MJ: Phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem 269: 27315–27321, 1994
Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF: Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72: 1189–1193, 1995
Ward A, Bates P, Fisher R, Richardson L, Graham CF: Disproportionate growth in mice with Igf-2transgenes. Proc Natl Acad Sci USA 91: 10365–10369, 1994
Kaleko M, Rutter WJ, Miller AD: Overexpression of the human IGF-I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10: 464–473, 1990
Sturm MA, Conover CA, Pham H et al: Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells. Endocrinology 124: 388–396, 1989
El-Badry OM, Romanus JA, Helman LJ et al: Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 84: 829–839, 1989
Kiess W, Lee L, Graham D et al: Rat C6 glial cell synthesize insulin-like growth factor I (IGF-I) and express IGF-I receptors and IGF-II/mannose 6-phosphate receptors. Endocrinology 124: 1727–1736, 1989
Trojan J, Blossey B, Johnson T et al: Loss of tumorigenicity of rat glioblastoma directed by episome based antisense cDNA transcription of insulin-like growth factor-I. Proc Natl Acad Sci USA 89: 4874–4878, 1992
Lichtor T, Kurakus MA, Gurney ME: Differential expression of insulin-like growth factor II in human meningiomas. Neurosurgery 29: 405–410, 1991
Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Van Obberghen E: Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 48: 1233–1237, 1988
Antoniades HN, Galalnopoulos T, Neveill-Goldne J, Maxwell M: Expression of IGFs I and II and their receptor mRNAs in primary astrocytomas and meningiomas: in vivo studies using in situ hybridization and immunohistochemistry. Int J Cancer 50: 215–222, 1992
Grundberger G, Lowe W, McElduff A, and Glick RP: Insulin Receptor of Human Cerebral Gliomas. J Clin Invest 77: 997–1005, 1986
Glick RP, Gettleman R, Patel K, Tsibris J, Unterman TG: Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery 24: 791–797, 1989
Prisell P, Persson L, Boethius J, Sara V: Somatomedins in tumor cyst fluid, CSF, and tumor cytosol in patients with glial tumors. Acta Neurochir Wien 89: 48–52, 1987
Glick RP, Unterman TG, Hollis R: Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors. J Neurosurg 74: 972–978, 1991
Glick RP, Unterman TG, Van Der Woude M, Blaydes L: Insulin and insulin-like growth factors in CNS tumors. V. Production of IGFs I and II in vitro. J Neurosurg 77: 445–50, 1992
Glick RP, Unterman T: Radioimmunoassay of IGF-I and II in the CSF of Patients with Pituitary and other CNS Tumors. Neurosurg 36: 556–564, 1994
Ballard J, Baxter R, Binoux M et al: Reports on the nomenclature of the IGF binding proteins. J Clin Endocrinol Metab 817: 818–819, 1970
Baxter R, Martin J: Binding proteins for the insulin-like growth factors, structure, regulation, and function. Prog Growth Factor Res 1: 49–68, 1989
Busby R, Klapper D, Clemmons D: Purification of a 31,000 dalton insulin like factor binding protein from amniotic fluid. J Biol Chem 263: 14203–14210, 1988
Yeoh S, Baxter R: Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol 119: 465–473, 1988
Tseng L, Brown A, Yang Y et al: The fetal rat binding protein for insulin like growth factors is expressed in the choroid plexus and CSF of rats. Mol Endocrinol 3: 1559–69, 1989
Romanus J, Terrel J, Yang Y et al: Insulin-like growth factor carrier proteins in neonatal and adult rat serum are immunologically different: demonstration using a new radioimmunoassay for the carrier protein from BRL-3A rat liver cells. Endocrinol 118: 1743–1758, 1986
Shimasaki S, Uchiyama F, Shimonaka M et al: Molecular cloning of the cDNA encoding a novel insulin-like growth factor-binding protein from rat and human. Mol Endocrinol 4: 1451–58,1990
Mohan S, Bautista C, Wergdal, Baylink J: Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell conditioned medium; a potential local regulator of IGF action. Proc Natl Acad Sci USA 86: 8338–8342, 1990
Shimasaki S, Ling N: Identification and molecular characterization of insulin-like binding protein (IGF BP)-1,-2,-3,-4,-5 and-6. Prog Growth Factor Res 3: 243–266, 1991
Hintz R: Plasma forms of somatomedin and the binding protein phenomenoa. Clin Endocrinol Metab 13: 31–42, 1984
DeMellow J, Baxter R: Growth hormone dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156: 199–204, 1988
Elgin R, Busby W, Clemmons D: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84: 3254–3258
Unterman TG, Glick RP, Waites G, Bell S: Production of insulin like growth factor binding proteins by human central nervous system tumors. Cancer Res 51: 3030–3036, 1991
Muller HL, Oh Y, Gargosky SE, Lehrnbecher T et al: Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis. J Clin Endocrinol Metab 77: 1113–1119, 1993
Huff K, Knabbe C, Linsay R et al: Multihormonal regulation of insulin-like growth factor-I related protein in MCF-7 human breast cancer cells. Mol Endocrinol 2: 200–208, 1988
Clemmons D, Camacho-Hubner C, Coronado C, Osborne K: Insulin like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127: 2679–2688, 1990
Rausing A, Ybo W, Stenflo J: Intracranial meningioma: a population study of ten years. Acta Neurol Scand 46: 102–110, 1970
Bickerstaff ER, Small J, Guest I: The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21: 89–91, 1958
Rand C, Andler M: Tumors of the brain complicating pregnancy. Arch Neurol Psychiatry 63: 1–41, 1950
Olson J, Beck D, Schlechte J et al: Effect of the antiprogesterone RU-38486 in meningioma implanted into nude mice. J Neurosurg 66: 584–587, 1987
Koper J, Foekens J, Braakman R et al: Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells. Cancer Res 50: 2604–2607, 1990
Jay JR, MacLaughlin D, Riley K et al: Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62: 757–762, 1985
Weisman A, Villemure T, Kelly P: Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 46: 2545–2550, 1986
Schoenberg B, Christine B, Whisnat J: Nervous system neoplasms and primary malignancies of other sites: the unique association between meningiomas and breast cancer. Neurology NY 25: 705–712, 1975
Glick RP, Molteni A, Fors EM: Hormone binding in brain tumors. Neurosurgery 13: 513–519, 1983
DiChiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith P, Smith B, Patronas N, Kufta C, Kessler P, Johnson G, Manning R, Wolf A: Glucose utilization of cerebral gliomas measured by 18-flurodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329, 1984
DiChiro G, Hatazawa J: Glucose utilitzation by intracranial meningioma as an index of tumor agressivity and probability of recurrence. A PET Study. Radiology 164: 512, 1987
Watanabe A, Tanaka R, Takeda N, Washiyama K: DNA systhesis, blood flow and glucose utilization in experimental rat brain tumors. J Neurosurg 70: 86–91, 1989
Bell GI, Kayano T, Buse J, Burant C, Taleda J, Lin D, Fukumoto H, Seino S: Molecular biology of mammalian glucose transporters. Diabetes Care 13: 198–208, 1990
Flier J, Mueckler M, McCall A, Lodish H: Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man. J Clin Invest 79: 657–661, 1987
Kalaria R, Gracina S, Schmidley JW, Perry G, Harik S: The glucose transporter of the human brain and blood brain barrier. Ann Neurol 24: 757–764, 1988
Pardridge W, Boado R, Farrell C: Brain-type glucose transporter (Glut-1) is selectively localized to the blood brain barrier. Studies with quantitative Western blotting and in situ hybridization. J Biol Chem 265: 18035–18040, 1990
Maher F, Vanycci S, Takeda J, Simpson I: Expression of mouse GLUT 3 and human GLUT 3 glucose transporter proteins in brain. Biochem Biophys Res Commun 182: 703–711, 1992
Gerhart D, Broderius M, Borson N, Dreives L: Neurons and microvessels express brain glucose transporter protein GLUT 3. Proc Natl Acad Sci 89: 733–737, 1992
Masters BA, Raizada MK: Insulin-like Growth Factor I Receptors and IGF-I actions in Neuronal Cultures from the Brain. Annals NY Acad Sci 692: 89–101, 1993
Werner H, Raizada M, Muss L, Foyt H, Simpson I, Roberts C, LeRoith D: Regulation of rat brain/Hep G2 glucose transporter gene expression by insulin and insulin-like growth factor-I in primary cultures of neuronal and glial cells. Endocrinology 125: 314–320, 1989
Glick RP, Untermann TG, Lacson R: Identification of insulin like growth factor (IGF) and glucose transporter-1 and-3 mRNA in CNS tumors. Regulatory Peptides 48: 251–256, 1993
Goldstein G: The glucose transporter and blood brain barrier of human brain tumors. Ann Neurol 28: 758–765, 1990
Nishioka T, Oda Y, Seino Y, Yamamoto T, Inagaki N, Yano H, Imura H, Shigemoto R, Kikuchi H: Distribution of glucose transporters in human brain tumors. Cancer Res 53: 3972–3979, 1992
Hall W, Flores E, Low W: Antisense oligonucleotides of central nervous sytem tumors. Neurosurg 38: 376–383, 1996
Trojan J, Johnson TR, Rudin SD, Ilan JU, Tykocinski M, Ilan J: Treatment and prevention of rat glioblastoma directed by immunogenic antisense IGF-1 tumor transfectants. Science 259: 94–97, 1993
Trojan J, Blossey BK, Johnson TR, Rudin SD, Tykoncinski M, Ilan JU, Ilan J: Loss of tumorogenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin like growth factor 1. Proc Natl Acad Sci USA 89: 4874–4878, 1992
Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R: Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54: 2218–2222, 1994
Baserga R: The insulin-like growth factor 1receptor: A key to tumor growth? Cancer research 55: 249–252, 1995
Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kahuria S, Chen E, Jakobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y: Insulin-like growth factor 1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503–2512, 1986
Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R: Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA 90: 11217–11221, 1993
Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, De Angelis T, Rubin R, Efstratiadis A, Baserga R: Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14: 3604–3612, 1994
Glick RP, Lichtor T, Taylor C, Griffitt W, Resnicoff M, Baserga R: Stimulation of Anti-tumor Immune Responses by Anti-sense IGF-IR Oligonucleotides. Proc of 2nd Biennial Tumor Satellite Symposium, Montreal, 1996, p 15
Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer 65: 311–320, 1992
Pastan I, Fitzgerald D: Recombinant toxins for cancer treatment. Science 254: 1173–1177, 1991
Kunwar S, Pai LH, Pastan I: Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. J Neurosurg 79: 569–576, 1993
Flier J, Usher Pk, Moses A: Monoclonal antibody to the type I IGF-I receptor blocks IGF-I receptor mediation DNA synthesis. Proc Natl Acad Sci 83: 664–668, 1986
Snelling L, Miyamoto CT, Bender H, Brady LW et al: Epidermal growth factor receptor 425 monoclonal antibodies radiolabled with iodine-125 in the adjuvant treatment of high grade astrocytomas. Hybridoma 14: 111–114, 1995
Dadparvar S, Krishna L, Miyamoto C, Brady LW et al: Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas. Cancer 73: 884–889, 1994
Tsutsumi K, Kitagawa N, Niwa M, Himeno A, Taniyama K, Shibata S: Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells. J Neurosurg 80: 502–509, 1994
Stoll BA: The growth hormone/insulin like growth factor axis and breast cancer rish. Breast 2: 130–133, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glick, R.P., Lichtor, T. & Unterman, T.G. Insulin-like growth factors in central nervous system tumors. J Neurooncol 35, 315–325 (1997). https://doi.org/10.1023/A:1005876819455
Issue Date:
DOI: https://doi.org/10.1023/A:1005876819455